Regarding pharmacological prevention, only a small sample of retrospective studies has shown that tamoxifen reduces the risk of breast cancer in healthy carriers of the BRCA2 gene mutation by 62% (288 cases, 11 with BRCA2 mutation).[32]. This evidence concerns the gene BRCA2 and breast carcinoma.